He is the Director of Research and Development for the CLIA lab of the Division of Clinical and Translational Genetics. He is also the Director of the Oncogenomics Core Facility (OCF) at the Sylvester Cancer Center and the Director for New Technology Assessment and Implementation, Hussman Institute for Human Genomics (HIHG)-Center for Genome Technology. He worked at Bayer Diagnostics and Digene developing tests and tools including HCV and HPV genotyping assays. One of his primary objectives is to evaluate and acquire next-gen technology in the field of genomics and molecular diagnostics and implement it for both research and clinical utilization.